AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
4
Halozyme Therapeutics
HALO
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -29.45%26.05M | 6.37%11.41M | -5.20%9.76M | -41.24%6.38M | -129.66%-1.5M | -10.42%36.92M | 22.16%10.73M | -21.90%10.29M | -4.98%10.85M | -35.56%5.05M |
Net income from continuing operations | -8.38%27.05M | 9.03%7.28M | 1.30%7.57M | -16.54%6.17M | -24.46%6.02M | -24.29%29.52M | -27.38%6.68M | -25.93%7.47M | -26.04%7.39M | -17.87%7.97M |
Operating gains losses | -135.59%-139K | -125.90%-567K | 178.21%217K | 79.25%95K | 90.16%116K | 86.21%-59K | -0.40%-251K | 7,700.00%78K | 260.61%53K | 141.78%61K |
Depreciation and amortization | 4.84%2.21M | 1.47%552K | 3.27%569K | 5.22%544K | 9.90%544K | 6.20%2.11M | 11.25%544K | 10.42%551K | 1.77%517K | 1.43%495K |
Deferred tax | 199.24%1.05M | 315.04%938K | -95.00%11K | -338.00%-219K | 121.95%319K | -693.82%-1.06M | 42.14%226K | 858.62%220K | 74.75%-50K | -690.65%-1.45M |
Other non cashItems | -41.88%204K | -78.52%64K | 134.67%95K | -3.45%28K | -94.30%17K | -66.12%351K | 225.74%298K | -135.31%-274K | 116.57%29K | -55.65%298K |
Change in working capital | -260.67%-6.34M | -39.19%1.61M | -25.55%1.54M | -146.69%-1.12M | -163.03%-8.37M | 198.11%3.94M | 292.02%2.65M | 110.13%2.07M | 478.13%2.41M | 21.36%-3.18M |
-Change in other current assets | -696.18%-5.41M | -85.71%883K | 110.81%682K | -114.78%-997K | 18.01%-5.98M | 96.83%-680K | 161.28%6.18M | -12.04%-6.31M | 69.88%6.75M | 24.81%-7.3M |
-Change in other current liabilities | -119.96%-923K | 120.55%726K | -89.72%862K | 97.10%-126K | -157.96%-2.39M | -73.46%4.62M | -140.58%-3.53M | 26.67%8.38M | -22.11%-4.34M | -27.27%4.12M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -29.45%26.05M | 6.37%11.41M | -5.20%9.76M | -41.24%6.38M | -129.66%-1.5M | -10.42%36.92M | 22.16%10.73M | -21.90%10.29M | -4.98%10.85M | -35.56%5.05M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -8.81%-217.42M | -483.60%-33.05M | 37.93%-43.69M | -41.30%-103.58M | 42.68%-37.11M | 19.30%-199.81M | 316.46%8.62M | 38.99%-70.38M | 21.02%-73.3M | -82.70%-64.74M |
Proceeds payment in interest bearing deposits in bank | -9,179.02%-18.61M | -114.05%-4.9M | 146.34%15.93M | -2,408.05%-30.22M | -37.28%577K | -99.67%205K | -43.83%34.88M | 19.87%-34.39M | 72.88%-1.21M | -98.09%920K |
Net investment purchase and sale | 9.05%18.64M | -67.27%7.67M | 97.02%-504K | -72.48%2.07M | 207.86%9.4M | 139.65%17.09M | 342.86%23.44M | -503.17%-16.91M | 198.71%7.51M | 113.25%3.05M |
Net proceeds payment for loan | 1.36%-212.16M | 31.60%-34.06M | -216.04%-59.7M | 5.13%-74.19M | 35.17%-44.21M | 19.63%-215.08M | 12.35%-49.8M | 72.95%-18.89M | 3.55%-78.19M | -13.85%-68.2M |
Capital expenditure | 44.02%-1.48M | -156.28%-979K | 93.34%-111K | 1.67%-59K | 38.02%-326K | -87.68%-2.64M | -59.83%-382K | -2,774.14%-1.67M | 85.15%-60K | 25.18%-526K |
Net PPE purchase and sale | 33.33%4K | --4K | ---- | ---- | ---- | -92.11%3K | --0 | ---- | ---- | ---- |
Net other investing changes | -732.12%-3.82M | -264.84%-783K | -53.16%690K | 13.01%-1.18M | -28,411.11%-2.55M | -60.57%604K | -24.72%475K | 475.39%1.47M | -298.39%-1.35M | 124.32%9K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -8.81%-217.42M | -483.60%-33.05M | 37.93%-43.69M | -41.30%-103.58M | 42.68%-37.11M | 19.30%-199.81M | 316.46%8.62M | 38.99%-70.38M | 21.02%-73.3M | -82.70%-64.74M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 8.69%187.07M | 181.76%14.14M | -36.45%41.25M | 68.38%101.14M | -52.60%30.54M | -17.44%172.1M | -82.42%-17.29M | -38.84%64.91M | -27.45%60.07M | 121.99%64.42M |
Increase decrease in deposit | -43.12%125.59M | 8,293.82%22.53M | 24.54%124.64M | -12.27%29.09M | -157.70%-50.67M | -13.61%220.79M | -103.08%-275K | -15.14%100.08M | -64.53%33.16M | 149.20%87.82M |
Net issuance payments of debt | 326.50%76.63M | 64.40%-4.75M | -152.77%-79.59M | 147.85%75.84M | 534.28%85.13M | -2.96%-33.83M | 10.22%-13.34M | -281.90%-31.49M | 529.53%30.6M | -645.32%-19.6M |
Net commonstock issuance | 15.52%655K | 10.63%229K | 7.96%217K | 17.39%216K | 72.00%-7K | 9.25%567K | 0.00%207K | -0.99%201K | 2.22%184K | 64.79%-25K |
Cash dividends paid | -2.50%-15.8M | 0.23%-3.88M | -3.32%-4.01M | -3.38%-4.01M | -3.55%-3.91M | -4.32%-15.42M | -3.44%-3.88M | -3.41%-3.88M | -3.44%-3.88M | -7.19%-3.77M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 8.69%187.07M | 181.76%14.14M | -36.45%41.25M | 68.38%101.14M | -52.60%30.54M | -17.44%172.1M | -82.42%-17.29M | -38.84%64.91M | -27.45%60.07M | 121.99%64.42M |
Net cash flow | ||||||||||
Beginning cash position | 40.54%31.94M | 17.54%35.14M | 10.92%27.82M | -13.05%23.88M | 40.54%31.94M | 10.15%22.73M | 9.07%29.89M | 6.92%25.08M | 24.52%27.46M | 10.15%22.73M |
Current changes in cash | -146.73%-4.31M | -466.21%-7.5M | 51.96%7.32M | 265.52%3.94M | -270.55%-8.07M | 340.02%9.21M | 143.76%2.05M | 21.80%4.82M | -269.83%-2.38M | 233.80%4.73M |
End cash position | -13.48%27.64M | -13.48%27.64M | 17.54%35.14M | 10.92%27.82M | -13.05%23.88M | 40.54%31.94M | 40.54%31.94M | 9.07%29.89M | 6.92%25.08M | 24.52%27.46M |
Free cash flow | -28.33%24.57M | 0.83%10.43M | 11.84%9.65M | -41.46%6.32M | -140.32%-1.82M | -13.88%34.28M | 21.11%10.34M | -34.26%8.63M | -2.04%10.79M | -36.58%4.52M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |